Literature DB >> 23793204

Cutaneous malakoplakia: case report and review.

João Paulo Junqueira Magalhães Afonso1, Patricia Naomi Ando, Maria Helena Valle de Queiroz Padilha, Nilceo Schwery Michalany, Adriana Maria Porro.   

Abstract

Malakoplakia is a rare acquired disease that can affect many systems but is more common in the urogenital tract. Cutaneous malakoplakia is even rarer. It is far more frequent in immunodeficient patients. We report a case of cutaneous malakoplakia in a kidney transplant patient who had recently stopped receiving immunosuppressive therapy to illustrate a review of the relevant recent literature.

Entities:  

Mesh:

Year:  2013        PMID: 23793204      PMCID: PMC3754379          DOI: 10.1590/abd1806-4841.20131790

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Malakoplakia is a term derived from the Greek, meaning "soft plaque".[1,2] The disease was first described in 1902 by Michaelis and Gutman.[3] It describes a granulomatous process of infectious etiol ogy triggered by bacteria that occurs preferentially in subjects affected by primary or secondary immunodeficiency.[4,5] The pathogenesis of malakoplakia remains poorly understood, and it is thought to represent an acquired bactericidal defect of macrophages associat ed with infection, immunosuppression, and/or immunosuppressive agentes.[4.6,7] The most common site of occurrence is the urogenital tract, although the condition has also been found to affect the gastrointestinal and respiratory tracts, retroperitoneum, thyroid gland, lymph nodes, bones/joints, middle ear, eyes and brain.[4-9] The condition has been considered rare, and cutaneous malako plakia is even rarer; the first case was reported by Leclerc and Bernier in 1972.[10] We report a case of cutaneous malakoplakia in a kidney transplant recipient and proceed with a review of the topic.

CASE REPORT

A 51-year-old white man from Brazil, suffering from idiopathic chronic renal failure, presented with a immunosuppressive agentes.[4.6,7] 2-year history of asymptomatic cutaneous lesion on the left groin, noticed by his nephrologist during hospitalization due to sepsis caused by catheter infection. The patient was frequently catheterized at this site since an unsuccessful kidney transplantation 2 years before. The lesion was a yellow-erythematous-purple plaque measuring around 1 cm in diameter, on the left groin, near a femoral vein catheter (Figure 1).
FIGURE 1

Malakoplakia: Picture of the yellow-erythematous- purple plaque measuring little more than 1 cm in diameter on the left groin of the patient near a femoral vein cateter

Malakoplakia: Picture of the yellow-erythematous- purple plaque measuring little more than 1 cm in diameter on the left groin of the patient near a femoral vein cateter The lesion was sampled for histopathologic and culture studies. The culture results revealed the growth of Providentia spp and Candida albicans. Histopathologic analysis revealed a chronic inflammatory process characterized by sheets of closely packed macrophages containing PAS-positive inclusions (von Hansemann cells) and calcospherites known as Michaelis-Gutmann bodies, as demonstrated by Von Kossa stain, which shows the homogeneous bodies in black (Figures 2A, 2B e 2C). Prussian blue staining demonstrated the presence of hemosiderin inside macrophages, which may explain the purple color of the lesion (Figure 2D).
FIGURE 2

Malakoplakia: A-hematoxylin-eosin (400 X) stain showing the sheets of macrophages. B-von Hansemann cells in PAS stain (400 X)(black arrow). C-Michaelis- Gutmann bodies, shown in black after Von Kossa staining (400 X)(black arrow). D-Prussian blue demonstrates hemosiderin inside macrophages (400 X)

Malakoplakia: A-hematoxylin-eosin (400 X) stain showing the sheets of macrophages. B-von Hansemann cells in PAS stain (400 X)(black arrow). C-Michaelis- Gutmann bodies, shown in black after Von Kossa staining (400 X)(black arrow). D-Prussian blue demonstrates hemosiderin inside macrophages (400 X) The patient was treated with surgical excision in association with sulfametoxazol-trimetoprin antibiotic therapy. No evidence of recurrence was detected on 3-year follow-up, as shown in figure 3.
FIGURE 3

Malakoplakia: Left groin picture of the same patient after treatment and 3-year follow-up

Malakoplakia: Left groin picture of the same patient after treatment and 3-year follow-up

DISCUSSION

Malakoplakia is a rare granulomatous disease in which a defect of the killing capacity of macrophages after endocytosis is considered to be the central event. Disturbed phagosome-lysosome fusion was suggested, but it is still not clear how and why this disorder happens, and the hypothesis is not fully accepted.[11-13] We reviewed published articles in indexed periodicals that appeared in a PubMed search performed using the term "cutaneous malakoplakia". Based on Kohl et al. 2008, we added cases of cutaneous malakoplakia published from January 2006 until January 2012, as demonstrated in chart 1. 14
CHART 1

Reported cases of cutaneous Malakoplakia

Reported Cases of Cutaneous Malakoplakia in the Literature*

Case No.Reference No.Age/SexLocationGrossMedical History
1551 y/MPerianal, inguinal, scrotumNodules and ulcerationsKidney Tx
2567 y/MRight templeNoduleKidney Tx
33369 y/FRight axillaUlceration and massRA, breast carcinoma
43440 y/FInguinal, broad ligamentUlcerationN/A
51064 y/MPerianalIndurated massRA
63535 y/MLeft eyelidNoduleKidney Tx
7164 y/MPerianalUlcerationLymphoma
83675 y/FVulvaUlcerationRA
93750 y/FAbdominal woundPolypoid massN/A
103831 y/MRight axillaMassHIV
11932 y/MAbdomenAbdomen AbscessKidney Tx
12944 y/MPerianal and left lungAbscessKidney Tx
13942 y/MRight axillaChronic abscessSLE
143970 y/MButtockNoduleChronic hepatitis C
154075 y/MRight hand and wristAbscessN/A
164141 y/MPeritoneal, supraclavicularCystic mass and firm noduleDM
174274 y/MPerianalNonhealing lesionMPD
184355 y/MGluteal cleftUlcersHIV
194467 y/MLeft neckMassNo significant PMH
204581 y/FFrontal massIrregular plaqueDM
214656 y/MInternal canthus of eyeNoduleSarcoidosis
223244 y/FButtockNoduleKidney Tx
234760 y/FNasolabial sulcusUlcerationN/A
24142 mo/MColorectal and perianalPolypoid massesImmunodeficiency
25268 y/MLeft inguinal regionPapulesN/A
26266 y/MRight axillaNoduleRA, DM
274853 y/FPerineumPapulesKidney Tx
284942 y/MInguinal regionMass with ulcerationLymphoma
295041 y/MFrontal scalp, right lungAbscess, pulmonary lesionsHIV, Hepatitis B
305164 y/FLeft neck massMass with cavitationThyroidectomy
315260 y/MGluteal foldCutaneous fistulaDM
325362 y/MChestUlcerationN/A
335465 y/MUreterocutaneous fistulaAbdominal fistulaN/A
341951 y/MPerianalNoduleHeart Tx
355569 y/MLeft arm and flankUlceration, massEscherichia coli sepsis
365655 y/FAbdominal wallPapulesN/A
375722 y/FArmFluctuating massN/A
385852 y/FInferior abdomenFistula with abscessKidney Tx
395930 y/MPerianalAbscessesDermatomyositis
406051 y/MLeft thighMass with draining abscessHIV, DM
411660 y/FAbdominal foldPink-yellow plaquesHealthy
421723 y/MPerianalPink nodulesHealthy
431814 Y/MGluteal foldPapuleHealthy
442055 y/FRight Labia"Boil" (nodule + abscess)Heart Tx
452758 y/MPerianalErosive plaquePsoriasis
466163 y/FAbdominal wallFistulaPulmonary sarcoidosis
476283 y/FNeckGoma (nodule + fistula)SLE, RA, Sjogren
486345 y/FPerigenitalPapules, nodules and sinusesHIV
496424 y/MAbdominal wallFistulaPsoas abscess (Tuberculosis?)
506587 y/MButtockScaly plaques and polypoid nodulesNo significant PMH
516666 y/MLower abdomenAbscesses, nodules and fistulaPoor overall health
52current article case51 y/MLeft groinPlaqueKidney Tx
Reported cases of cutaneous Malakoplakia While the majority of subjects are immunodeficient patients, including HIV-infected patients, patients with neoplasia, transplanted patients and others, more recently cases involving previously healthy patients have been reported.[15-17] Almost all transplanted patient cases refer to kidney recipients, as the one in this article, but two were reported in heart transplant recipients.[18,19] There are few reports in which prevalence among women is higher (2:1).[20,21] The age peak occurs between the sixth and seventh decades, being even rarer in children.[17,22] Approximately 90% of patients have coliform bacteria detected in urine, blood, or tissue, suggesting an infectious cause.[4] The most commonly found bacterium is Escherichia coli, but Klebsiella, Proteus, Pseudomonas, Mycobacterium avium, Mycobacterium tuberculosis, Shigella, Staphylococcus aureus and Enterococcus spp were also found.[23,24] Rhodococcus equi is the most commonly implicated microbe in HIV-infected patients.[25] In 75% of cases, the disease affects the genitourinary tract, but other systems have been implicated, including the skin.[26] No typical clinical presentation is described, skin presentation varies from papules, plaques, nodules, abscesses with or without fluctuation, and fistula to ulcers, cystic and polypoid masses.[14] Therefore, the diagnosis is predominantly confirmed by anatomopathologic and culture studies. Vanbrabant et al.2004 recently described the possibility of using 18fluoro-deoxyglucose positron emission tomography for diagnosis and follow-up.[27] Histopathologically, the pathognomonic finding of Michaelis-Gutmann bodies, which represent partially degraded bacterial organisms, can establish the diagnosis. Michaelis-Gutmann bodies are intracytoplasmic, round-ovoid, basophilic, concentric laminated inclusions in macrophages that are typically enlarged and display foamy cytoplasm and eccentric, hyperchromatic, round nuclei, denoted as Hansemann cells. Differential diagnosis is possible with other infectious diseases or neoplastic and reactive/reparative processes. Infections to consider include tuberculosis, Whipple's disease, lepromatous leprosy, fungus (Cryptococcus), and parasites (leishmaniasis). Special stains for microorganisms and tissue culture are necessary. Reactive and neoplastic processes include Langerhans cell histiocytosis, fibrous histiocytoma, lymphoma, granular cell tumor, xanthoma, foreign-body granuloma, hemophagocytic syndromes, and sarcoidosis.[14] Although generally presenting benign self-limited evolution, a fatal outcome is possible, but none was described in cutaneous malakoplakia.[28] Pseudomalakoplakia was once described as a proliferation of histiocytes at a previous surgical site, but only as an abstract. No other publications on this theme are found.[29] Our observation that the disease developed on a site of recognized trauma and contamination, in accordance with other related cases, highlights the importance of direct inoculation of bacteria in the pathophysiology, since the presence of immunosuppression is necessary, but not sufficient for its development. There are no prospective comparative studies, probably due to the limited incidence, so approaches to management vary from surgical excision, with or without antibiotics, to the use of antibiotics alone.[8] Van der Voort et al. 1996 compared treatments and concluded that surgical excision achieved the higher cure rate (90%), and that, when comparing antibiotics, quinolones seemed to be superior.[7] The discontinuation of immunosuppressives and treatment of HIV could also be helpful.[7,9] Sulfamethoxazole-trimethoprim is also cited as effective.[30] It was selected by us due to considerations such as cost, access and drug interaction. We illustrated this article reporting a case of cutaneous malakoplakia synchronous to previous immunosuppressive therapy, in a subject with no current immunosuppressive treatment. The option for surgical plus antibiotic treatment resulted in cure with no recurrence to date. We also reviewed the literature and counted the reported cases of cutaneous malakoplakia described on chart 1 (including this one).[31-66]
  60 in total

Review 1.  Cutaneous malacoplakia: a report of two cases and review of the literature.

Authors:  M H Lowitt; A L Kariniemi; K M Niemi; G F Kao
Journal:  J Am Acad Dermatol       Date:  1996-02       Impact factor: 11.527

2.  Cutaneous malakoplakia.

Authors:  Michael Sormes; Ute Siemann-Harms; Johanna M Brandner; Ingrid Moll
Journal:  J Dtsch Dermatol Ges       Date:  2011-09-07       Impact factor: 5.584

3.  Malakoplakia in the gastrointestinal tract of a liver transplant recipient.

Authors:  R Rull; L Grande; J C García-Valdecasas; J A Bombi; L L Alós; J Fuster; A M Lacy; E Cugat; F X Gonzalez; A Rimola
Journal:  Transplantation       Date:  1995-05-27       Impact factor: 4.939

4.  [Cutaneous malacoplakia associated with chronic hepatitis caused by hepatitis C virus].

Authors:  I Bodokh; J P Lacour; C Perrin; C Rainero; E Lebreton; E Grosshan; J P Ortonne
Journal:  Ann Dermatol Venereol       Date:  1993       Impact factor: 0.777

Review 5.  [Cutaneous malacoplakia in heart transplanted patient].

Authors:  B Rémond; A Dompmartin; M De Pontville; A Moreau; J C Mandard; D Leroy
Journal:  Ann Dermatol Venereol       Date:  1993       Impact factor: 0.777

6.  Malacoplakia: extensive female genital tract and skin involvement.

Authors:  A Baez-Giangreco; M Afzal; S K Chattopadhyay
Journal:  Int J Gynaecol Obstet       Date:  1994-05       Impact factor: 3.561

Review 7.  Cutaneous malacoplakia.

Authors:  B Rémond; A Dompmartin; A Moreau; P Esnault; A Thomas; J C Mandard; D Leroy
Journal:  Int J Dermatol       Date:  1994-08       Impact factor: 2.736

8.  Prediagnostic malakoplakia presenting as a chronic inflammatory mass in the soft tissues of the neck.

Authors:  A G Douglas-Jones; C Rodd; E M James; R G Mills
Journal:  J Laryngol Otol       Date:  1992-02       Impact factor: 1.469

Review 9.  Malacoplakia. Two case reports and a comparison of treatment modalities based on a literature review.

Authors:  H J van der Voort; J A ten Velden; R P Wassenaar; J Silberbusch
Journal:  Arch Intern Med       Date:  1996-03-11

10.  Cutaneous malacoplakia.

Authors:  B Sarkell; M Dannenberg; W K Blaylock; J W Patterson
Journal:  J Am Acad Dermatol       Date:  1994-05       Impact factor: 11.527

View more
  6 in total

Review 1.  A Case of Cutaneous Malakoplakia in the Head and Neck Region and Review of the Literature.

Authors:  Matthew Coates; Marcos Martinez Del Pero; Ramez Nassif
Journal:  Head Neck Pathol       Date:  2016-05-06

2.  Cutaneous malakoplakia presenting as a groin swelling and graft failure.

Authors:  Ross Andrew Macdonald; Colin Moyes; Marc Clancy; Peter Douglas
Journal:  BMJ Case Rep       Date:  2019-04-23

3.  Cutaneous malakoplakia masquerading as pyoderma gangrenosum.

Authors:  Mariam Smith-Pliego; Jose Contreras-Ruiz; Siobhan Ryan; R Gary Sibbald; Wedad Hanna; Rodrigo Roldan-Marin
Journal:  Int Wound J       Date:  2016-08-15       Impact factor: 3.315

4.  Malakoplakia affecting the umbilical cord.

Authors:  Song-Hee Han; Mee Joo; Sunhee Chang; Han-Seong Kim
Journal:  J Pathol Transl Med       Date:  2015-03-12

5.  A case of primary cutaneous malakoplakia in a cardiac transplant recipient.

Authors:  Dena Elkeeb; Zachary Hopkins; David Wada; Jamie L W Rhoads
Journal:  JAAD Case Rep       Date:  2018-10-29

6.  An ulcerated violaceous nodule on the thigh.

Authors:  Kelsey E Hirotsu; Anusha M Kumar; Kerri E Rieger; Jennifer K Chen
Journal:  JAAD Case Rep       Date:  2021-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.